Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) – Initiating Coverage


January 10, 2024
 / 
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”) is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria that have been classified as priority pathogens.